Stakeholder one-day event Nano2Clinic – Synergies for Clinical Translation of Nanotechnology in Cancer Therapies

This page is dedicated to our Stakeholder one-day event Nano2Clinic – Synergies for Clinical Translation of Nanotechnology in Cancer Therapies, which took place in Zagreb on Masrch 3, 2023.

All presentations for which we received permission to publish along with the meting program can be donwloaded from this page.

To watch a short meeting video please ckick here.

Useful downloads

Risk Assessment in Nanomedicine Needs for harmonisation, standardisation and validation by Maria Dusinska

Novel Approaches to Theranostic Nanomedicine Design by Marco Giardiello

The importance of having the right policies and regulations in place to ensure patient safety...by Mike Isles

Best practice: Clinical translation of a orphan nanodrug by Elisabet González Mira

Phoenix - Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products by Nazende Gunday-Tureli

Regulatory aspects of Clinical translation of nano-enabled products by Blanca Suarez-Merino

Meeting program